Post-approval studies (Phase 4)Study completedNCT00319189
What this trial is testing
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
Who this might be right for
Renal Transplant RecipientsPosttransplant Diabetes MellitusPosttransplant Impaired Glucose Tolerance
University of Oslo School of Pharmacy 15